560-561 / 1152
Too much:
•
Redundancy in publications
•
Engineering of new devices
•
Treatment planning studies
Too little:
•
Few clinical trials
•
No gold standard for technology
•
Limited true 4D treatment
•
New treatment technology (protons and MR-RT)
awaiting 4D solutions